Shopping Cart
Remove All
Your shopping cart is currently empty
Gotistobart (ONC-392; BNT 316) is a humanized monoclonal antibody targeting CTLA-4/CD152 that selectively depletes regulatory T cells (Tregs) in the tumor microenvironment and enhances immunotherapy efficacy, applicable for studying non-small cell lung cancer (NSCLC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $619 | - | In Stock | |
| 10 mg | $993 | - | In Stock | |
| 25 mg | $1,470 | - | In Stock | |
| 50 mg | $1,990 | - | In Stock |
| Description | Gotistobart (ONC-392; BNT 316) is a humanized monoclonal antibody targeting CTLA-4/CD152 that selectively depletes regulatory T cells (Tregs) in the tumor microenvironment and enhances immunotherapy efficacy, applicable for studying non-small cell lung cancer (NSCLC). |
| Synonyms | ONC-392, ONC392, BNT316, BNT 316 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | CTLA-4 |
| Cas No. | 2226344-78-9 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | YTE-SA-EAKA |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.